輸入代號或公司名稱後按 Enter
6242

立康

+0.10 (+0.30%)最後更新 2026-09-15
台灣 · 上櫃 · 生技醫療業
33.809成交張數14.08本益比1.28股價淨值比5.92%殖利率2026-09-15資料日期

綜合損益表公開資訊觀測站申報原值 · 年度(第 4 季累計) · 每一格 = 該科目 ÷ 營業收入

營業收入2025589年增 +4.2%
毛利率202567.6%最新一期
營業利益率202516.7%最新一期
每股盈餘20252.64年增 +6.5%
會計項目走勢2016201720182019202020212022202320242025
銷貨收入淨額100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%
營業收入合計100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%
營業成本合計32.6%31.8%31.5%31.1%34.2%31.6%43.2%32.3%31.7%32.4%
營業毛利(毛損)67.4%68.2%68.5%68.9%65.8%68.4%56.8%67.7%68.3%67.6%
營業毛利(毛損)淨額67.4%68.2%68.5%68.9%65.8%68.4%56.8%67.7%68.3%67.6%
推銷費用43.1%41.8%41.9%42.3%39.4%43.9%30.5%39.1%44.0%43.2%
管理費用9.4%9.2%8.3%8.3%8.7%9.7%6.3%7.4%8.4%7.7%
營業費用合計52.6%51.1%50.1%50.6%48.1%53.6%36.7%46.5%52.4%50.9%
營業利益(損失)14.8%17.1%18.4%18.3%17.7%14.8%20.1%21.2%15.9%16.7%
利息收入0.3%0.3%0.2%0.5%1.1%0.8%
其他收入0.2%0.6%1.1%0.9%1.5%1.9%0.5%0.4%0.5%0.4%
其他利益及損失淨額-0.5%10.0%0.1%-0.1%-0.4%-0.5%-0.2%0.1%0.2%-0.2%
財務成本淨額0.4%0.2%0.2%0.2%0.1%0.1%0.0%0.1%0.1%0.1%
營業外收入及支出合計-0.7%10.4%1.1%0.6%1.3%1.6%0.5%0.9%1.6%1.0%
稅前淨利(淨損)14.1%27.5%19.4%18.9%19.0%16.4%20.6%22.1%17.5%17.7%
所得稅費用(利益)合計0.5%0.5%3.9%4.0%3.9%3.1%4.2%4.5%3.9%3.4%
繼續營業單位本期淨利(淨損)13.7%27.0%15.5%14.9%15.2%13.3%16.4%17.6%13.6%14.2%
本期淨利(淨損)13.7%27.0%15.5%14.9%15.2%13.3%16.4%17.6%13.6%14.2%
透過其他綜合損益按公允價值衡量之權益工具投資未實現評價損益-1.5%-0.1%-0.7%-0.3%-0.8%
不重分類至損益之項目:-1.5%-0.1%-0.7%-0.3%-0.8%
其他綜合損益(淨額)-1.5%-0.1%-0.7%-0.3%-0.8%
本期綜合損益總額13.7%27.0%15.5%14.9%15.2%11.8%16.3%16.9%13.4%13.4%
母公司業主(淨利∕損)17.6%13.6%14.2%
母公司業主(綜合損益)16.9%13.4%13.4%
基本每股盈餘0.6%1.2%0.7%0.7%0.7%0.6%0.7%0.7%0.4%0.4%
繼續營業單位淨利(淨損)0.0%0.0%0.0%0.0%0.0%
稀釋每股盈餘0.6%1.2%0.7%0.7%0.7%0.6%0.7%0.7%0.4%0.4%
其他收益及費損淨額-0.0%-0.0%-0.0%0.0%0.0%0.0%
研究發展費用0.1%0.0%0.0%0.0%0.0%
其他收益0.0%0.0%

金額為公司申報原值除以一千(百萬元,四捨五入),每股金額為元。年度為第 4 季的年初至今累計數。走勢條是歷史各期的相對大小,藍為正、綠為負。年增以去年同期為基期,基期非正數或變動超過十倍時不列。 權益變動表在申報資料分頁。